Tags : LysaKare

Novartis’ LysaKare (arginine hydrochloride/lysine hydrochloride) Solution Receives CHMP’s Positive Opinion

Shots: The positive opinion recommendation follows the study assessing arginine and lysine of same content as LysaKare, evaluating its safety and efficacy The EC will review CHMP’s opinion with its expected results within three months, if approved will be a novel solution of this concentration available in EU   LysaKare 25g/25g is a solution to […]Read More